These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 12374689

  • 1. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM, Belch AR.
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [Abstract] [Full Text] [Related]

  • 2. Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice.
    Pilarski LM, Hipperson G, Seeberger K, Pruski E, Coupland RW, Belch AR.
    Blood; 2000 Feb 01; 95(3):1056-65. PubMed ID: 10648422
    [Abstract] [Full Text] [Related]

  • 3. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES, Guikema JE, Scherpen F, Meeuwsen T, Kamps WA, Vellenga E, Bos NA.
    Cancer Res; 2001 Oct 15; 61(20):7654-9. PubMed ID: 11606408
    [Abstract] [Full Text] [Related]

  • 4. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R.
    Haematologica; 2008 Mar 15; 93(3):347-55. PubMed ID: 18268278
    [Abstract] [Full Text] [Related]

  • 5. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM, Cavo M, Fortuna A.
    J Hematother; 1996 Aug 15; 5(4):339-49. PubMed ID: 8877709
    [Abstract] [Full Text] [Related]

  • 6. Analysis of human hematopoietic stem cell populations.
    Murray L, DiGiusto D, Chen B, Chen S, Combs J, Conti A, Galy A, Negrin R, Tricot G, Tsukamoto A.
    Blood Cells; 1994 Aug 15; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [Abstract] [Full Text] [Related]

  • 7. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D, Mazzucato M, Abbruzzese L, Cilli M, De Angeli S, Degan M, Mambrini G, Piccardi F, Rupolo M, Michieli M, De Marco L, Gattei V, Astori G.
    Vox Sang; 2008 May 15; 94(4):342-50. PubMed ID: 18282263
    [Abstract] [Full Text] [Related]

  • 8. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM, Giannakopoulos NV, Szczepek AJ, Masellis AM, Mant MJ, Belch AR.
    Clin Cancer Res; 2000 Feb 15; 6(2):585-96. PubMed ID: 10690543
    [Abstract] [Full Text] [Related]

  • 9. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A, Papadimitriou C, Serve H, Hoppe B, Koenigsmann M, Reufi B, Oberberg D, Thiel E, Berdel WE.
    Bone Marrow Transplant; 1997 Jun 15; 19(12):1239-46. PubMed ID: 9208119
    [Abstract] [Full Text] [Related]

  • 10. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D, Gross A, Kosova N, Fichtner I, Salama A.
    Transfusion; 2005 Jul 15; 45(7):1192-200. PubMed ID: 15987366
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E, Björkstrand B, Treschow A, Aints A, Smith CI, Gahrton G, Dilber MS.
    Cancer Gene Ther; 2007 Mar 15; 14(3):227-32. PubMed ID: 17082794
    [Abstract] [Full Text] [Related]

  • 12. Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.
    Hirai M, LaFace D, Robinson S, Kelsey L, Johnson R, Wen SF, Warkentin P, Mills K, Vaillancourt M, Chavez J, Leutzinger C, Sumegi J, Neugebauer S, Lehman J, Talmadge C, Maneval D, Talmadge J.
    Cancer Gene Ther; 2001 Dec 15; 8(12):936-47. PubMed ID: 11781656
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
    Samira S, Ferrand C, Peled A, Nagler A, Tovbin Y, Ben-Hur H, Taylor N, Globerson A, Lapidot T.
    Stem Cells; 2004 Dec 15; 22(6):1085-100. PubMed ID: 15536198
    [Abstract] [Full Text] [Related]

  • 14. Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.
    Di Nicola M, Siena S, Corradini P, Bregni M, Milanesi M, Magni M, Ruffini PA, Ravagnani F, Tarella C, Gianni AM.
    Bone Marrow Transplant; 1996 Dec 15; 18(6):1117-21. PubMed ID: 8971381
    [Abstract] [Full Text] [Related]

  • 15. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
    Hicks C, Isaacs A, Wong R, Chong BH.
    Ann Hematol; 2011 May 15; 90(5):547-55. PubMed ID: 20957366
    [Abstract] [Full Text] [Related]

  • 16. Interaction with human stromal cells enhances CXCR4 expression and engraftment of cord blood Lin(-)CD34(-) cells.
    Kobune M, Kawano Y, Takahashi S, Takada K, Murase K, Iyama S, Sato T, Takimoto R, Niitsu Y, Kato J.
    Exp Hematol; 2008 Sep 15; 36(9):1121-31. PubMed ID: 18562079
    [Abstract] [Full Text] [Related]

  • 17. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ, Kruisselbrink AB, Lurvink E, Mulder A, Claas FH, Noort WA, Willemze R, Fibbe WE.
    Exp Hematol; 2005 Oct 15; 33(10):1249-56. PubMed ID: 16219548
    [Abstract] [Full Text] [Related]

  • 18. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
    Abonour R, Scott KM, Kunkel LA, Robertson MJ, Hromas R, Graves V, Lazaridis EN, Cripe L, Gharpure V, Traycoff CM, Mills B, Srour EF, Cornetta K.
    Bone Marrow Transplant; 1998 Nov 15; 22(10):957-63. PubMed ID: 9849692
    [Abstract] [Full Text] [Related]

  • 19. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
    Szczepek AJ, Seeberger K, Wizniak J, Mant MJ, Belch AR, Pilarski LM.
    Blood; 1998 Oct 15; 92(8):2844-55. PubMed ID: 9763569
    [Abstract] [Full Text] [Related]

  • 20. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
    Li K, Li CK, Chuen CK, Tsang KS, Fok TF, James AE, Lee SM, Shing MM, Chik KW, Yuen PM.
    Eur J Haematol; 2005 Feb 15; 74(2):128-35. PubMed ID: 15654904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.